My ePortfolio Register   

Abemaciclib for advanced breast cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.09.17
Views: 1078

Dr Angelo Di Leo - Hospital of Prato, Tuscany, Italy

Dr Di Leo speaks with ecancer at the ESMO 2017 Congress in Madrid about the MONARCH 3 trial investigating the use of abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer. 

Watch Dr Di Leo present the data in a press conference for more, and read our news coverage here.

ecancer also hosted a round table discussion of CDK4/6 inhibitors at ESMO, which you can watch here.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence